Going through medical treatment is often similar to a long journey. The term “patient journey” refers to all the stages along this path – prevention, the emergence of the first symptoms of a disease, recovery, the ongoing management of a chronic…
The Charité BIH Innovation team established a new event series to expand the matching and connecting activities and to create a broader platform: The Future Tech Days – where digital health startups and members of Charité meet for a short pitch…
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) today signed a licence agreement with Qi Kang Medical, Ltd (QKM), a joint venture between Eckert & Ziegler and the Chinese company DC Pharma, for the cyclotron technology used by Eckert & Ziegler to…
Researchers at the Experimental and Clinical Research Center in Berlin are developing a targeted treatment for muscular dystrophy with the help of gene-editing. Preclinical research led by the Spuler Lab published in “Nature Communications” now paves…
For years, the idea that "AI will replace radiologists" has been largely speculative. Today, a groundbreaking study published in Nature Medicine provides the first real-world evidence of artificial intelligence's potential to transform breast…
ProBioGen today announces the expansion of both protein and virus manufacturing at its Berlin headquarters. This includes the commissioning of an additional 1000L-scale GMP production line for proteins as well as the completion of the construction…
Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler), a leading provider of isotope technology for nuclear medicine and radiopharmaceutical applications, announces the submission of its GalliaPharm® 68Ge/68Ga Radionuclide Generator for approval in…
International research team describes for the first time the structure and function of the Zorya system, a highly specialised antiviral protection mechanism of bacteria
Slow brain waves make neocortex especially receptive
First closing of funding round supported by Brandenburg Kapital, High-Tech Gründerfonds, existing and new private investors; second closing expected by the end of Q1 2025
Funds to be used in preparing for upcoming approval and product launch of…
